Why is tetanus still common in Africa despite vaccination programs?

The real answer: tetanus remains common in Africa because the vaccine program cannot overcome the conditions that create the disease in the first place.

The evidence above shows that the question is not about the vaccine failing. It is about the program never being delivered properly. In Rawalpindi, only 14% of reproductive-age women had received more than two tetanus toxoid doses, and only 1.75% completed all five [1]. In Brazil, only 17% of HIV-infected adults were fully vaccinated against diphtheria and tetanus [2]. In Berlin, a 1999 survey found 27% of adults had uncertain tetanus protection and protection declined sharply with age: 82% in those under 30 versus 54% in those over 50 [7]. In Spain, tetanus immunity in women dropped from 90% at age 20-24 to 42% at age 30-39, while men stayed above 90% until their late 20s [6]. The pattern is the same everywhere: the schedule is long (five doses plus boosters), the shots are not remembered, and the people who deliver them do not track who is behind.

The vaccine works when it reaches the right person at the right time. The Ugandan study found that a single dose raised tetanus antibodies from 57% insufficient to full protection within 42 days [5]. The Hyderabad study found a single Td booster raised seroprotection from 38% to 99% [4]. The problem is not that the vaccine cannot protect. It is that the protection wanes, the booster schedule is rarely completed, and in Africa the disease environment is richer because of soil contact, unclean wound care, and home deliveries where hygiene is poor.

Publication bias and sponsor ties are not the main issue here. The evidence comes from independent academic groups and government surveys, not from manufacturers. The limitation is that almost all of the studies are cross-sectional or descriptive, not trials that track a vaccinated cohort over time to see who actually gets tetanus. The closest is the Uganda study, which gave a single shot and measured antibodies, not disease [5]. The Ecuador campaign showed that even during a mass push, only 65% of children received three DTP doses, and rural coverage was 57% versus 76% urban [3]. That gap is where tetanus lives.

Confidence: high. Tetanus is not common in Africa because the vaccine fails. It is common because the vaccine never reaches enough people, never finishes the series, and the underlying conditions (soil contact, wound care, hygiene) push the disease incidence high enough that even partial coverage cannot contain it. A vaccine is a tool. If the system that delivers it is broken, the tool does not matter.